Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif

被引:68
作者
Shirakawa, Kotaro [1 ,2 ]
Takaori-Kondo, Akifumi [1 ]
Yokoyama, Masaru [3 ]
Izumi, Taisuke [1 ]
Matsui, Masashi [1 ]
Io, Katsuhiro [1 ]
Sato, Toshihiro [4 ]
Sato, Hironori
Uchiyama, Takashi [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Sakyo Ku, Kyoto 6068507, Japan
[2] Japanese Fdn AIDS Prevent, Chiyoda Ku, Tokyo 1010061, Japan
[3] Natl Inst Infect Dis, Ctr Pathogen Genom, Lab Viral Genom, Tokyo 2080011, Japan
[4] Japan Tobacco Inc, Cent Pharmaceut Res Inst, Osaka 5691125, Japan
关键词
D O I
10.1038/nsmb.1497
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G, referred to here as A3G) is a potent antiretroviral host factor against human immunodeficiency virus type 1 (HIV-1). HIV-1 viral infectivity factor (Vif) counteracts A3G by promoting its degradation via the ubiquitin-proteasome pathway. Recent studies demonstrated that protein kinase A (PKA) phosphorylates activation-induced deaminase (AID), another member of the APOBEC3 family. A3G has two putative PKA phosphorylation residues. Here we show that PKA binds and specifically phosphorylates A3G at Thr32 in vitro and in vivo. This phosphorylation event reduces the binding of A3G to Vif and its subsequent ubiquitination and degradation, and thus promotes A3G antiviral activity. Computer- assisted structural modeling and mutagenesis studies suggest that the interaction between A3G Thr32 and Arg24 is crucial for interaction with Vif. These data imply that PKA-mediated phosphorylation of A3G can regulate the interaction between A3G and Vif.
引用
收藏
页码:1184 / 1191
页数:8
相关论文
共 37 条
[11]   HUMAN-IMMUNODEFICIENCY-VIRUS PROTEINS INDUCE THE INHIBITORY CAMP PROTEIN KINASE-A PATHWAY IN NORMAL LYMPHOCYTES [J].
HOFMANN, B ;
NISHANIAN, P ;
NGUYEN, T ;
INSIXIENGMAY, P ;
FAHEY, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) :6676-6680
[12]   Molecular mechanism of class switch recombination: Linkage with somatic hypermutation [J].
Honjo, T ;
Kinoshita, K ;
Muramatsu, M .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :165-196
[13]   Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and virion encapsidation [J].
Huthoff, Hendrik ;
Malim, Michael H. .
JOURNAL OF VIROLOGY, 2007, 81 (08) :3807-3815
[14]   Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function [J].
Kobayashi, M ;
Takaori-Kondo, A ;
Miyauchi, Y ;
Iwai, K ;
Uchiyama, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (19) :18573-18578
[15]   APOBEC3G targets specific virus species [J].
Kobayashi, M ;
Takaori-Kondo, A ;
Shindo, K ;
Abudu, A ;
Fukunaga, K ;
Uchiyama, T .
JOURNAL OF VIROLOGY, 2004, 78 (15) :8238-8244
[16]   Phosphorylation of HIV Nef by cAMP-dependent protein kinase [J].
Li, PL ;
Wang, T ;
Buckley, KA ;
Chenine, AL ;
Popov, S ;
Ruprecht, RM .
VIROLOGY, 2005, 331 (02) :367-374
[17]   Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts [J].
Mangeat, B ;
Turelli, P ;
Caron, G ;
Friedli, M ;
Perrin, L ;
Trono, D .
NATURE, 2003, 424 (6944) :99-103
[18]   A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to vif action [J].
Mangeat, B ;
Turelli, P ;
Liao, SY ;
Trono, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (15) :14481-14483
[19]   Cytidine deamination induced HIV-1 drug resistance [J].
Mulder, Lubbertus C. F. ;
Harari, Ariana ;
Simon, Viviana .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (14) :5501-5506
[20]   Highly conserved configuration of catalytic amino acid residues among calicivirus-encoded proteases [J].
Oka, Tomoichiro ;
Yamamoto, Mami ;
Yokoyama, Masaru ;
Ogawa, Satoko ;
Hansman, Grant S. ;
Katayama, Kazuhiko ;
Miyashita, Kana ;
Takagi, Hirotaka ;
Tohya, Yukinobu ;
Sato, Hironori ;
Takeda, Naokazu .
JOURNAL OF VIROLOGY, 2007, 81 (13) :6798-6806